ES2321708T3 - Uso de acidos alf-feniltiocarboxilicos con antividad de reduccion de glucosa serica y reduccion de lipidos sericos. - Google Patents

Uso de acidos alf-feniltiocarboxilicos con antividad de reduccion de glucosa serica y reduccion de lipidos sericos. Download PDF

Info

Publication number
ES2321708T3
ES2321708T3 ES03780669T ES03780669T ES2321708T3 ES 2321708 T3 ES2321708 T3 ES 2321708T3 ES 03780669 T ES03780669 T ES 03780669T ES 03780669 T ES03780669 T ES 03780669T ES 2321708 T3 ES2321708 T3 ES 2321708T3
Authority
ES
Spain
Prior art keywords
phenylthio
ethoxy
acid
methyl
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03780669T
Other languages
English (en)
Spanish (es)
Inventor
Fabio c/o Sigma-Tau Industrie GIANNESSI
Emanuela c/o Sigma-Tau Industrie TASSONI
Maria Ornella c/o Sigma-Tau Industrie TINTI
Pompeo c/o Sigma-Tau Industrie PESSOTTO
Natalina c/o Sigma-Tau Industrie DELL'UOMO
Anna Floriana c/o Sigma-Tau Industrie SCIARRONI
Tiziana c/o Sigma-Tau Industrie BRUNETTI
Ferdinando c/o Sigma-Tau Industrie MILAZZO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2321708T3 publication Critical patent/ES2321708T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/134—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings monocyclic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
ES03780669T 2002-12-19 2003-12-16 Uso de acidos alf-feniltiocarboxilicos con antividad de reduccion de glucosa serica y reduccion de lipidos sericos. Expired - Lifetime ES2321708T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000629A ITRM20020629A1 (it) 2002-12-19 2002-12-19 Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
ITRM02A0629 2002-12-19

Publications (1)

Publication Number Publication Date
ES2321708T3 true ES2321708T3 (es) 2009-06-10

Family

ID=32676886

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03780669T Expired - Lifetime ES2321708T3 (es) 2002-12-19 2003-12-16 Uso de acidos alf-feniltiocarboxilicos con antividad de reduccion de glucosa serica y reduccion de lipidos sericos.

Country Status (20)

Country Link
US (1) US7375124B2 (https=)
EP (1) EP1572180B1 (https=)
JP (1) JP2006512362A (https=)
KR (1) KR20050085222A (https=)
CN (1) CN100393309C (https=)
AR (1) AR042547A1 (https=)
AT (1) ATE423558T1 (https=)
AU (1) AU2003288546B8 (https=)
BR (1) BR0317359A (https=)
CA (1) CA2506627A1 (https=)
DE (1) DE60326382D1 (https=)
DK (1) DK1572180T3 (https=)
ES (1) ES2321708T3 (https=)
IT (1) ITRM20020629A1 (https=)
MX (1) MXPA05005848A (https=)
PL (1) PL378414A1 (https=)
PT (1) PT1572180E (https=)
SI (1) SI1572180T1 (https=)
TW (1) TWI308564B (https=)
WO (1) WO2004056355A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006045010A2 (en) * 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
WO2008092231A1 (en) 2007-02-01 2008-08-07 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
KR101629356B1 (ko) 2008-06-26 2016-06-13 리스버로직스 코퍼레이션 퀴나졸리논 유도체의 제조방법
MX2011002448A (es) * 2008-09-05 2011-05-25 Acucela Inc Compuestos enlazados con azufre para el tratamiento de enfermedades y trastornos oftalmicos.
AU2010204106B2 (en) 2009-01-08 2014-05-08 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
NZ755378A (en) 2009-03-18 2022-07-29 Resverlogix Corp Novel quinazolinones and related compounds for use as anti-inflammatory agents
KR20190091564A (ko) 2009-04-22 2019-08-06 리스버로직스 코퍼레이션 신규한 소염제
RU2640115C2 (ru) 2011-11-01 2017-12-26 Ресверлоджикс Корп. Фармацевтические композиции замещенных хиназолинонов
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
AU2013365926B9 (en) 2012-12-21 2019-01-17 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
JO3789B1 (ar) 2015-03-13 2021-01-31 Resverlogix Corp التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة
CN114901641B (zh) * 2020-02-28 2025-06-17 四川科伦博泰生物医药股份有限公司 芳香族化合物及其药物组合物和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
GB1121722A (en) * 1966-03-31 1968-07-31 Ici Ltd New carboxylic acid derivatives
GB1422679A (en) * 1972-11-16 1976-01-28 Funai Pharmaceutical Ind Ltd Substituted phenoxy-a-methylpropionic acid derivatives and a process for producing the same
FR2285867A1 (fr) * 1974-09-30 1976-04-23 Lafon Labor Derives du diphenylsulfoxyde
ITRM20020014A1 (it) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del

Also Published As

Publication number Publication date
CN1728992A (zh) 2006-02-01
ITRM20020629A1 (it) 2004-06-20
ATE423558T1 (de) 2009-03-15
DK1572180T3 (da) 2009-06-02
AU2003288546B8 (en) 2009-06-11
SI1572180T1 (sl) 2009-06-30
US20060154979A1 (en) 2006-07-13
TWI308564B (en) 2009-04-11
WO2004056355A1 (en) 2004-07-08
DE60326382D1 (de) 2009-04-09
EP1572180B1 (en) 2009-02-25
MXPA05005848A (es) 2005-08-26
TW200420531A (en) 2004-10-16
US7375124B2 (en) 2008-05-20
AU2003288546B2 (en) 2009-04-30
CA2506627A1 (en) 2004-07-08
PT1572180E (pt) 2009-05-04
BR0317359A (pt) 2005-11-08
EP1572180A1 (en) 2005-09-14
AR042547A1 (es) 2005-06-22
AU2003288546A1 (en) 2004-07-14
CN100393309C (zh) 2008-06-11
JP2006512362A (ja) 2006-04-13
KR20050085222A (ko) 2005-08-29
PL378414A1 (pl) 2006-04-03
HK1087007A1 (en) 2006-10-06

Similar Documents

Publication Publication Date Title
ES2321708T3 (es) Uso de acidos alf-feniltiocarboxilicos con antividad de reduccion de glucosa serica y reduccion de lipidos sericos.
US7728158B2 (en) PPAR activity regulators
ES2265952T3 (es) Derivados de ariltiazolidindiona y ariloxazolidindiona.
CN101596191B (zh) 用作代谢调节剂的丙二酰基辅酶a脱羧酶抑制剂
ES2277842T3 (es) Derivados de ariltiazolidindiona y de ariloxazolidindiona.
US20080027098A1 (en) Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation
ES2281146T3 (es) Ariltiazolidindionas utiles como compuestos terapeuticos.
RU2746602C2 (ru) Агонисты ppar, соединения, фармацевтические композиции и способы их применения
JP2010526807A (ja) 抗糖尿病活性を有する縮合芳香族化合物を用いた治療法
JP2003523336A (ja) 糖尿病及び脂質障害のためのアリールオキシ酢酸
US10456405B2 (en) Nitric oxide-releasing prodrug molecule of substituted quinazolines
EA037371B1 (ru) Агонисты ppar, соединения, фармацевтические композиции и способы их применения
KR20040081107A (ko) 페닐（알킬）카르복시산 유도체 및 디이온성페닐알킬헤테로사이클릭 유도체, 및 혈청 글루코스및／또는 혈청 지질 강하 활성을 갖는 약제로서의 그의 용도
KR101275770B1 (ko) ＰＰＡＲα/γ/δ 효능제로 작용하는 알콕시 인돌-3-아세트산 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
ES2353149T3 (es) Derivados de hidroxifenol, procesos para su preparación, composiciones farmacéuticas que las comprenden y su uso terapéutico.
HK1087007B (en) Use of a-phenylthiocarboxylic and a-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
EA039833B1 (ru) Агонисты ppar, соединения, фармацевтические композиции и способы их применения